Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Phyllis Chan

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Pharmaceutical Research|February 17, 2022
Applications of Model-Based Meta-Analysis in Drug DevelopmentPhyllis Chan, Kirill Peskov, Xuyang Song
CPT: Pharmacometrics & Systems Pharmacology|June 24, 2017
Developing a Natural History Progression Model for Duchenne Muscular Dystrophy Using the Six-Minute Walk TestLora Hamuro, Phyllis Chan, Giridhar Tirucherai, et al.
Cancer Chemotherapy and Pharmacology|July 6, 2023
External validation of a tumor growth inhibition-overall survival model in non-small-cell lung cancer based on atezolizumab studies using alectinib dataNastya Kassir, Phyllis Chan, Steve Dang, et al.
The AAPS Journal|November 6, 2025
Utilizing Minimal Physiologically Based Pharmacokinetic Modeling to Bridge Bevacizumab Pharmacokinetics from Adult to Pediatric PatientsOlagoke Sule, Felix Stader, Nastya Kassir, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 25, 2023
Comparison of two-stage and joint TGI-OS modeling using data from six atezolizumab clinical studies in patients with metastatic non-small cell lung cancerAntonio Gonçalves, Mathilde Marchand, Phyllis Chan, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 6, 2020
Application of Machine Learning for Tumor Growth Inhibition - Overall Survival Modeling PlatformPhyllis Chan, Xiaofei Zhou, Nina Wang, et al.
Clinical Pharmacokinetics|June 20, 2016
Using Population Pharmacokinetic and Pharmacodynamic Analyses of Entecavir in Pediatric Subjects to Simplify Dosing RecommendationsPhyllis Chan, Diane R Mould, Malaz Abu Tarif, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 13, 2017
Model-based Meta-Analysis on the Efficacy of Pharmacological Treatments for Idiopathic Pulmonary FibrosisPhyllis Chan, Leon Bax, Chunlin Chen, et al.
Liver Cancer|November 1, 2021
Atezolizumab and Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Pharmacokinetic and Safety Assessments Based on Hepatic Impairment Status and Geographic RegionColby S Shemesh, Phyllis Chan, Hui Shao, et al.
Pharmaceutical Research|January 8, 2020
Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis [corrected]Phyllis Chan, Jiajie Yu, Leslie Chinn, et al.
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Pharmaceutical Research|February 17, 2022
Applications of Model-Based Meta-Analysis in Drug DevelopmentPhyllis Chan, Kirill Peskov, Xuyang Song
CPT: Pharmacometrics & Systems Pharmacology|June 24, 2017
Developing a Natural History Progression Model for Duchenne Muscular Dystrophy Using the Six-Minute Walk TestLora Hamuro, Phyllis Chan, Giridhar Tirucherai, et al.
Cancer Chemotherapy and Pharmacology|July 6, 2023
External validation of a tumor growth inhibition-overall survival model in non-small-cell lung cancer based on atezolizumab studies using alectinib dataNastya Kassir, Phyllis Chan, Steve Dang, et al.
The AAPS Journal|November 6, 2025
Utilizing Minimal Physiologically Based Pharmacokinetic Modeling to Bridge Bevacizumab Pharmacokinetics from Adult to Pediatric PatientsOlagoke Sule, Felix Stader, Nastya Kassir, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 25, 2023
Comparison of two-stage and joint TGI-OS modeling using data from six atezolizumab clinical studies in patients with metastatic non-small cell lung cancerAntonio Gonçalves, Mathilde Marchand, Phyllis Chan, et al.
CPT: Pharmacometrics & Systems Pharmacology|December 6, 2020
Application of Machine Learning for Tumor Growth Inhibition - Overall Survival Modeling PlatformPhyllis Chan, Xiaofei Zhou, Nina Wang, et al.
Clinical Pharmacokinetics|June 20, 2016
Using Population Pharmacokinetic and Pharmacodynamic Analyses of Entecavir in Pediatric Subjects to Simplify Dosing RecommendationsPhyllis Chan, Diane R Mould, Malaz Abu Tarif, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 13, 2017
Model-based Meta-Analysis on the Efficacy of Pharmacological Treatments for Idiopathic Pulmonary FibrosisPhyllis Chan, Leon Bax, Chunlin Chen, et al.
Liver Cancer|November 1, 2021
Atezolizumab and Bevacizumab in Patients with Unresectable Hepatocellular Carcinoma: Pharmacokinetic and Safety Assessments Based on Hepatic Impairment Status and Geographic RegionColby S Shemesh, Phyllis Chan, Hui Shao, et al.
Pharmaceutical Research|January 8, 2020
Population Pharmacokinetics, Efficacy Exposure-response Analysis, and Model-based Meta-analysis of Fenebrutinib in Subjects with Rheumatoid Arthritis [corrected]Phyllis Chan, Jiajie Yu, Leslie Chinn, et al.
Pageof 4